Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $53.85 USD
Change Today -1.52 / -2.75%
Volume 12.9M
As of 6:40 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Richard R. DeLuca Jr.

Executive Vice President and President of Merck Animal Health,Merck & Co. Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 4 different industries.

52--

Background*

Mr. Richard R. DeLuca, Jr., also known as Rick, has been Executive Vice President and President of Merck Animal Health at Merck & Co. Inc. since September 15, 2011. Mr. DeLuca served as the President of Veterinary Medicines Manufacturer at Wyeth Pharmaceuticals, Inc. He served as the President of Fort Dodge Animal Health Inc. of Wyeth since December 2007 and served as its Chief Operating Officer from June 29, 2007 to January 2008. He is responsible for all commercial, ...

Read Full Background

Corporate Headquarters*

2000 Galloping Hill Road
Kenilworth, New Jersey 07033

United States

Phone: 908-740-4000
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Bachelor's Degree
Widener University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MRK:US $53.85 USD -1.52

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Allergan plc
$500.0K
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€3.2M
Inge G. Thulin Chairman, Chief Executive Officer and President
3M Company
$1.4M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERCK & CO. INC., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.